Learn mode: Answer all statements, then click Submit Question to reveal the correct answers.
Question 150 / 5 answered
Regarding:Bronchial Asthma Management (GINA Guidelines)
Statement
TF
A
A.SABA short acting beta agonist is drug of choice for mild asthma.
B
B.ICS formeterol used for maintenance and releaving therapy (MART).
C
C.If symptoms well controlled can step down in 3 months.
D
D.PaCO2 increased in life threatening asthma.
E
E.Treatment response is considered achieved when FEV rises by >12% after bronchodilator use.
Scoring: +1 correct, -1 wrong, 0 not attempted · min 0 per question. You can leave any statement blank to avoid a penalty.